Eloxx Pharmaceuticals (ELOX) Reports Q1 Loss of $0.31/Share

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q1 EPS of ($0.31), versus ($0.73) reported last year.

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance